Syndax Pharmaceuticals Inc.

SNDX | NASDAQ

Price Alert Chart Builder DCF Calculator

$18.07

+$0.45 (+2.55%)

At close: Sep 21, 2026, 4:00 PM ET

$18.20

+$0.13 (+0.72%)

Pre-market: Sep 22, 2026, 8:31 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	172.35M	23.68M	n/a	n/a	139.71M	1.52M
Cost of Revenue	6.97M	826K	n/a	n/a	n/a	n/a
Gross Profit	165.38M	22.85M	n/a	n/a	139.71M	1.52M
Operating Income	-273.08M	-339.67M	-229.95M	-151.76M	26.22M	-71.42M
Interest Income	22.73M	26.09M	21.16M	5.87M	403K	841K
Pretax Income	-285.42M	-318.76M	-209.36M	-149.34M	24.93M	-73.16M
Net Income	-285.42M	-318.76M	-209.36M	-149.34M	24.93M	-73.07M
Selling & General & Admin	179.68M	120.88M	66.92M	33.26M	25.24M	22.51M
Research & Development	258.78M	241.65M	163.03M	118.5M	88.25M	50.44M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	438.47M	362.53M	229.95M	151.76M	113.49M	72.94M
Interest Expense	33.79M	4.93M	208K	3.14M	1.9M	2.36M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	445.44M	363.35M	229.95M	151.76M	113.49M	72.94M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	86.63M	85.62M	70.37M	60.76M	52.06M	41.31M
Shares Outstanding (Diluted)	86.63M	85.62M	70.37M	60.76M	52.06M	41.31M
EPS (Basic)	-3.29	-3.73	-2.98	-2.46	0.48	-1.77
EPS (Diluted)	-3.29	-3.73	-2.98	-2.46	0.48	-1.77
EBITDA	-251.63M	-313.82M	-209.14M	-146.17M	26.87M	-70.29M
EBIT	-251.64M	-313.83M	-209.15M	-146.2M	26.83M	-70.8M
Depreciation & Amortization	6K	8K	12K	33K	43K	515K